Clinical Efficacy of Cefditoren Pivoxil for Exacerbation of Chronic Obstructive Pulmonary Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 May 2017
At a glance
- Drugs Cefditoren pivoxil (Primary)
- Indications Bacterial infections; Chronic obstructive pulmonary disease; Respiratory tract infections
- Focus Therapeutic Use
- 23 May 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Feb 2015 Planned End Date changed from 31 Jul 2014 to 30 Apr 2017 as per University Hospital Medical Information Network - Japan record.
- 28 Feb 2014 Planned number of patients changed from 50 to 40 as reported by University Hospital Medical Information Network - Japan record.